English (United States)

EUPATI launches a new educational Toolbox on Medicines Research & Development

reduce font Size enlarge font Size print content

Contact: Rob Camp, Barcelona, Spain, +34.600207455, rob.camp@patientsacademy.eu 

EUPATI launches a new educational Toolbox on Medicines Research & Development

• More than 100 topics in 7 languages for patient advocates to discover, adapt and share
• Online information resource designed to enable more meaningful patient involvement 
• Information and education to help engage patients and patient advocates

(27 January 2016-Europe) – The European Patients’ Academy (EUPATI) today announces the launch of its new online Toolbox on Medicines Research & Development. The toolbox is available to European patient groups, patient advocates and anyone who is interested in learning more about the medicines research and development (R&D) process. Users can acquire the knowledge to make a meaningful contribution to medicines development and to the broader dialogue around patient empowerment. This online educational resource allows users to freely discover, adapt, and share materials.

To discover! adapt! and share! the EUPATI Toolbox now, visit www.eupati.eu 

To view our video of the Toolbox, https://vimeo.com/152251690 [English] https://vimeo.com/152542376 [French], https://vimeo.com/152412018 [German]

To join the conversation on patient education and patient involvement, get tweeting and posting on: https://twitter.com/EUPATI_Lux & www.facebook.com/EUPATI.Luxembourg

About EUPATI - The European Patients' Academy on Therapeutic Innovation provides scientifically reliable, objective, comprehensive information to patients and the general public on the research and development process of medicines. It will increase the capacity of patients and the lay public to be effective advocates and advisors, e.g., in clinical trials, with regulatory authorities and in ethics committees. EUPATI is a team of 33 organisations, led by the European Patients' Forum, made up of a unique combination of patient organisations, university and not-for-profit organisations expert in patient and public engagement, along with European pharmaceutical companies working in research. EUPATI wants to offer information and education that will help involve patients and patient advocates throughout the medicines research and development process.

EUPATI aims to make a visible difference to all stakeholders involved in medicines research and development, clarifying ways for a more meaningful involvement in areas like drug discovery, clinical trials planning and conduct, the assessment of safety of medicines, the balance of benefit and risk and health economics.
Find out more about the European Patients' Academy, including our ethics and transparency policies, in seven languages, at: http://www.patientsacademy.eu/index.php/en/about-eupati/10-independence

The "European Patients' Academy on Therapeutic Innovation" project is receiving support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115334, resources of which are composed of financial contribution from the European Union‘s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies.


@eupatients, @patientsinvolved

Who should register?

Healthcare professionals who wish to be part of a unique network, providing access to up-to-date, accurate and validated information about clinical research.

Investigators and study staff who wish to be part of a unique network, in order to stay abreast of clinical trials taking place in Luxembourg and who are willing to further develop their competencies.